» Articles » PMID: 29955514

Essential Oil of Lavender in Anxiety Disorders: Ready for Prime Time?

Overview
Specialty Psychiatry
Date 2018 Jun 30
PMID 29955514
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Anxiety disorders are some of the most common psychiatric disorders, with potentially debilitating consequences on individual function. Existing pharmacotherapies for anxiety disorders are limited by delay to therapeutic effect, dependence, tolerance, withdrawal, and abuse potential. Therefore, safe and evidence-based complementary or alternative therapies may be important allies in the care of patients with anxiety disorders. Essential oils are lipophilic and concentrated botanical extracts that exhibit many properties of drugs, although they are not Food and Drug Administration approved and have limitations characteristic of herbal preparations. Lavender essential oil has an extensive anecdotal history of anxiolytic benefit that has recently been supported by clinical efficacy studies. The 2 primary terpenoid constituents of lavender essential oil, linalool and linalyl acetate, may produce an anxiolytic effect in combination via inhibition of voltage-gated calcium channels, reduction of 5HT1 receptor activity, and increased parasympathetic tone. The objectives of this article are to provide a brief overview of lavender oil in aromatherapy, explore variability in the constituents of lavender oil, summarize its pharmacology and safety profile, as well as describe its body of research that has been conducted for anxiety.

Citing Articles

Aromatherapy and Essential Oils: Holistic Strategies in Complementary and Alternative Medicine for Integral Wellbeing.

Caballero-Gallardo K, Quintero-Rincon P, Olivero-Verbel J Plants (Basel). 2025; 14(3).

PMID: 39942962 PMC: 11821193. DOI: 10.3390/plants14030400.


Therapeutic Efficacy of 's Oil and Ethanol Extract in Regulation of the Neuroinflammation, Histopathological Alterations, Oxidative Stress, and Restoring Balance Treg Cells Expressing FoxP3+ in a Rat Model of Epilepsy.

Antar A, Abdel-Rehiem E, Al-Khalaf A, Abuelsaad A, Abdel-Gabbar M, Shehab G Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861097 PMC: 11768170. DOI: 10.3390/ph18010035.


The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial.

Naghdi M, Farshbaf-Khalili A, Nahaee J, Hakimi P, Shahnazi M BMC Complement Med Ther. 2024; 24(1):118.

PMID: 38459484 PMC: 10921632. DOI: 10.1186/s12906-024-04419-z.


Putative Mode of Action of the Monoterpenoids Linalool, Methyl Eugenol, Estragole, and Citronellal on Ligand-Gated Ion Channels.

Li A, Iijima A, Huang J, Li Q, Chen Y Engineering (Beijing). 2024; 6(5):541-545.

PMID: 38274392 PMC: 10810144. DOI: 10.1016/j.eng.2019.07.027.


Effectiveness of Aromatherapy in Early Palliative Care for Oncology Patients: Blind Controlled Study.

Khamis E, Abu Raddaha A, Nafae W, Al-Sabeely A, Ebrahim E, Elhadary S Asian Pac J Cancer Prev. 2023; 24(8):2729-2739.

PMID: 37642059 PMC: 10685211. DOI: 10.31557/APJCP.2023.24.8.2729.


References
1.
Howard S, Hughes B . Expectancies, not aroma, explain impact of lavender aromatherapy on psychophysiological indices of relaxation in young healthy women. Br J Health Psychol. 2007; 13(Pt 4):603-17. DOI: 10.1348/135910707X238734. View

2.
Prashar A, Locke I, Evans C . Cytotoxicity of lavender oil and its major components to human skin cells. Cell Prolif. 2004; 37(3):221-9. PMC: 6496511. DOI: 10.1111/j.1365-2184.2004.00307.x. View

3.
Landelle C, Francony G, Fouilhe Sam-Lai N, Gaillard Y, Vincent F, Wrobleski I . Poisoning by lavandin extract in a 18-month-old boy. Clin Toxicol (Phila). 2008; 46(4):279-81. DOI: 10.1080/15563650701281098. View

4.
Cha J, Lee S, Yoo Y . [Effects of aromatherapy on changes in the autonomic nervous system, aortic pulse wave velocity and aortic augmentation index in patients with essential hypertension]. J Korean Acad Nurs. 2010; 40(5):705-13. DOI: 10.4040/jkan.2010.40.5.705. View

5.
Spindelegger C, Lanzenberger R, Wadsak W, Mien L, Stein P, Mitterhauser M . Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Mol Psychiatry. 2008; 14(11):1040-50. DOI: 10.1038/mp.2008.35. View